[en] We demonstrated that the cephalosporin antibiotic ceftazidime (CAZ) deactivated singlet oxygen (1O2). We then studied the mechanisms of the CAZ effects on the ultra weak chemiluminescence (uwCL) associated with the energy decay of 1O2 generated by the Mallet reaction (H2O2 + HOCl --> HCl + H2O + 1O2), and on the anthracene-9,10-dipropionic acid (AAP) consumption by 1O2 generated by irradiation of Rose Bengal (RB). The uwCL generated by the Mallet reaction was amplified (6.2 times) by CAZ. The use of red and blue filters, which absorb radiation below 610 nm and between 470 and 700 nm respectively, demonstrated that CAZ increased the uwCL by a radiation emission at wavelengths shorter than the 633 and 704 nm wavelength emissions of 1O2. CAZ was excited by scavenging the energy excess of 1O2, which so returned to its fundamental state, while CAZ deactivated with light emission between 430-480 nm. CAZ also inhibited in a dose-dependent manner the consumption of AAP by 1O2 generated by the irradiation of RB. The protection of AAP by 5 x 10(-3) M CAZ was equivalent to that of 10(-3) M histidine and 3 X 10(-6) M sodium azide. This process of 1O2 deactivation will be useful in diseases characterized by an excessive PMN activation with a release of activated oxygen species.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Deby, Ginette ; Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Deby, C.
Mouithys-Mickalad, Ange ; Université de Liège - ULiège > Centre de l'oxygène : Recherche et développement (C.O.R.D.)
Hoebeke, Maryse ; Université de Liège - ULiège > Département de physique > Spectroscopie biomédicale
Mathy, Marianne ; Université de Liège - ULiège > Département des sciences de la motricité > Unité de recherche sur l'os et le cartillage (U.R.O.C.)
Jadoul, L.
Vandenberghe, A.
Lamy, Maurice ; Centre Hospitalier Universitaire de Liège - CHU > Anesthésie et réanimation
Language :
English
Title :
The antibiotic ceftazidime is a singlet oxygen quencher as demonstrated by ultra-weak chemiluminescence and by inhibition of AAP consumption.
S.J. Klebanoff, In: J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.), Inflammation, Basic Principles and Clinical Correlates, Raven Press, New York, 1988, pp. 391-444.
Weiss S.J. New Engl. J. Med. 320:1989;365-375.
Tagan M., Markert M., Schaller M., Feihl F., Chiolero R., Perret C. Am. J. Med. 91(Suppl 3c):1991;72S-78S.
Goode H.F., Webster N.R. Crit. Care Med. 21:1993;1770-1776.
Bellavite P. Free Radic. Biol. Med. 4:1988;225-261.
Lapenna D., Cellini L., De Giola S., Mezzetti A., Ciofani G., Festi D., Cuccurello F. Biochem. Pharmacol. 49:1995;1249-1254.
Fukase Y., Abe Y., Takahashi T., Ishikawa M. Chemotherapy. 37:1989;1195-1199.
Gunther M.R., Mao J., Cohen M.S. Antimicrob. Agents Chemother. 37:1993;950-956.
M. Mathy-Hartert, G. Deby-Dupont, C. Deby, L. Jadoul, A. Vandenberghe, M. Lamy, In: Abstr. of the 35th Interscience Conf. on Antimicrobial Agents and Chemother., San Francisco, CA, 17-20 Sept. 1995, p. 161, G 15.
G. Deby-Dupont, M. Mathy-Hartert, L. Jadoul, A. Vandenberghe, M. Lamy, C. Deby, In: Abstr. of the 34th Interscience Conf. on Antimicrobial Agents and Chemother., Orlando, FL, 4-7 Oct. 1994, p. 42, G 30.
Mathy-Hartert M., Deby-Dupont G., Deby C., Jadoul L., Vandenberghe A., Lamy M. Med. Inflammation. 4:1995;1-7.
Rawls H.R., Van Santen P.J. Ann. NY Acad. Sci. 171:1970;135-138.
Khan A.U., Kasha M. Nature. 204:1964;241-242.
Khan A.U., Kasha M. J. Am. Chem. Soc. 88:1966;1574-1576.
Kasha M., Kahn A.U. Annu. Rev. NY Acad. Sci. 171:1970;5-23.